BPC-157 is a 15amino acid peptide originally identified in gastric compounds
Mon - Fri: 9:00AM - 5:00PM 9301 Wilshire Blvd Suite 405, Beverly Hills, CA 90210 Although the FDA has yet to approve BPC-157 for humans, studies show that it has beneficial effects on stroke, schizophrenia, and spinal cord injury [1]
visible fine line and texture change at 68 weeks
While these results sound promising, the research is still in its early stages, and more studies are needed to know how reliable or meaningful these effects really are
Step 5: Storage Reconstituted research peptides are typically refrigerated immediately at 36-46F (2-8C) in published stability studies
Peptides such as BPC-157 and TB-500 are: Not FDA approved for treatment of any disease For research purposes only Intended for use under the supervision of a licensed, peptide-trained provider Only available to current patients All protocols are provided strictly for educational and informational purposes and should not be used without medical guidance